GlobalData on MSN4d
Senseonics and Ascensia announce FDA approval for one-year CGM system
Eversense 365 is said to be the world's first one-year CGM system, offering a new long-term solution for diabetes management.
drugdeliverybusiness5d
Senseonics wins FDA nod for 365-day implantable CGM
Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system.
bovnews3d
Jefferies Issues Underperform Rating for Senseonics Holdings Inc (SENS) Stock
Senseonics Holdings Inc (SENS) stock saw a decline, ending the day at $0.41 which represents a decrease of $-0.03 or -6.82% from the prior close of $0.44. The stock opened at $0.49 and touched a low ...
FierceBiotech5d
FDA clears Senseonics' 365-day Eversense CGM implant
After collecting FDA green lights for 90- and 180-day versions, the agency has cleared the latest generation of the Eversense ...
Yahoo Finance2d
Senseonics Holdings, Inc. (SENS)
GERMANTOWN, Md., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term ...
bovnews12d
Senseonics Holdings Inc (SENS) Stock: Understanding Its Underlying Value
Senseonics Holdings Inc (SENS) stock saw a modest uptick, ending the day at $0.34 which represents a slight increase of $0.02 or 6.25% from the prior close of $0.32. The stock opened at $0.33 and ...
HME News5d
Senseonics, Ascensia launch one-year CGM system
Senseonics and Ascensia Diabetes Care have announced that the U.S. Food and Drug Administration has cleared the next-generation Eversense 365 CGM, the first one-year CGM system ...
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of ...
ETF Daily News25d
Senseonics (NYSE:SENS) Now Covered by Analysts at StockNews.com
Analysts at StockNews.com started coverage on shares of Senseonics (NYSE:SENS – Get Free Report) in a research report issued to clients and investors on Wednesday. The brokerage set a “sell ...
Becker's Hospital Review5d
Glucose monitor receives FDA clearance
The FDA has cleared Senseonics and Ascensia Diabetes Care's Eversense 365 Glucose Monitoring System. This system is designed for Type 1 and Type 2 diabetics 18 and older and will be the first ...
Senseonics Announces first CGM
Senseonics Holdings, Inc. (NYSE: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with ...
Nasdaq16d
Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference
GERMANTOWN, Md., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term ...